UvA-DARE ( Digital Academic Repository ) Heparins , cancer and thrombosis : clinical and experimental studies

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.

  1999cited by this paper
• Inhibition of metastases by anticoagulants.

  1999cited by this paper
• VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels.

  1998cited by this paper
• Modulation of human endothelial cell proliferation and migration by fucoidan and heparin.

  1998cited by this paper
• Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells.

  1997cited by this paper
• Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.

  1997cited by this paper
• HGF/SF in angiogenesis.

  1997cited by this paper
• Endothelial proteoglycans inhibit bFGF binding and mitogenesis

  1997cited by this paper
• Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells.

  1997cited by this paper
• Insight into the profibrinolytic activity of heparin: effects on the activation of plasminogen mediated by urokinase

  1997cited by this paper
• Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis.

  1996cited by this paper
• A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

  1996cited by this paper
• The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration.

  1996cited by this paper
• Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis.

  1996cited by this paper
• Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain.

  1996cited by this paper
• Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

  1996cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Fibrinogen and fibrin – proteins with complex roles in hemostasis and thrombosis

  1996cited by this paper
• Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity

  1996cited by this paper
• Interaction of heparin with fibrinogen using surface plasmon resonance technology: investigation of heparin binding site on fibrinogen.

  1996cited by this paper
• Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

  1995cited by this paper
• Vascular Endothelial Growth Factor Increases Urokinase Receptor Expression in Vascular Endothelial Cells (*)

  1995cited by this paper
• Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.

  1995cited by this paper
• Effect of Low Molecular Weight Heparan Sulphate on Angiogenesis in the Rat Cornea After Chemical Cauterization

  1994cited by this paper
• Requirement of vascular integrin alpha v beta 3 for angiogenesis.

  1994cited by this paper
• Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis

  1994cited by this paper
• Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.

  1993cited by this paper
• Fibrinogen binds to heparin: the relationship of the binding of other adhesive proteins to heparin.

  1993cited by this paper
• Heparin and angiogenesis: a low-molecular-weight fraction inhibits and a high-molecular-weight fraction stimulates angiogenesis systemically.

  1993cited by this paper
• The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.

  1992cited by this paper
• Cancer and clotting--Trousseau's warning.

  1992cited by this paper
• Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

  1992cited by this paper
• Control of angiogenesis by heparin and other sulfated polysaccharides.

  1992cited by this paper
• Differential distribution and modulation of expression of alpha 1/beta 1 integrin on human endothelial cells

  1991cited by this paper
• Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma.

  1991cited by this paper
• Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

  1991cited by this paper
• Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition.

  1989cited by this paper
• Induction of angiogenesis during the transition from hyperplasia to neoplasia

  1989cited by this paper
• The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.

  1988cited by this paper
• New aspects of blood vessel growth: tumor and tissue-derived angiogenesis factors.

  1988cited by this paper
• Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors

  1987cited by this paper
• Effect of Thrombin on the Production of Plasminogen Activators and PA Inhibitor-1 by Human Foreskin Microvascular Endothelial Cells

  1987cited by this paper
• Angiogenic factors.

  1987cited by this paper
• Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing.

  1987cited by this paper
• A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

  1986cited by this paper
• Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

  1986cited by this paper
• Fibrin gel structure and clotting time.

  1982cited by this paper
• An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization.

  1979cited by this paper
• Size and density of fibrin fibers from turbidity.

  1978cited by this paper
• Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis.

  1977cited by this paper
• Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

  1973cited by this paper

• No citing papers are available for this paper.